Neurotrophins in the pathogenesis and potential treatment of Parkinson's disease
Bradford, H.F.; Zhou, J.; Pliego-Rivero, B.; Stern, G.M.; Jauniaux, E.
Advances in Neurology 80: 19-25
1999
ISSN/ISBN: 0091-3952 PMID: 10410698 Document Number: 501985
Document emailed within 1 workday
Related Documents
Nagatsu, T.; Mogi, M.; Ichinose, H.; Togari, A. 2000: Changes in cytokines and neurotrophins in Parkinson's disease Journal of Neural Transmission. Supplementum 2000(60): 277-290Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Saiki, S.; Hattori, N. 2009: Molecular genetics and pathogenesis of Parkinson disease No Shinkei Geka. Neurological Surgery 37(6): 531-541
Mizuno, Y.; Shimoda-Matsubayashi, S.; Matsumine, H.; Morikawa, N.; Hattori, N.; Kondo, T. 1999: Genetic and environmental factors in the pathogenesis of Parkinson's disease Advances in Neurology 80: 171-179
Hikasa, C.; Nakashima, K.; Nishikawa, S.; Takahashi, K.; Yanagihara, M. 1987: Event-related potential in Parkinson's disease Rinsho Shinkeigaku 27(7): 893-897
Koziorowski, D.; Jasztal, J. 1999: Factors which can play important role in pathogenesis of Parkinson disease Neurologia i Neurochirurgia Polska 33(4): 907-921
Möller, J.C.; Sautter, J.; Kupsch, A. 1996: Potential of neurotrophic factors in therapy of Parkinson's disease Journal of Neural Transmission. Supplementum 48: 103-112
Michałowicz, R.; Chmielik, J.; Ignatowicz, R.; Karkowska, B. 1982: Etiology and pathogenesis of Parkinson disease in children in the light of clinical observations Pediatria Polska 57(10): 811-815
Graham, D.G. 1984: Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease Neurotoxicology 5(1): 83-95
Katunina, E.A. 2005: Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis Eksperimental'naia i Klinicheskaia Farmakologiia 68(5): 16-18
Hattori, N.; Machida, Y.; Noda, K. 2005: Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation Rinsho Shinkeigaku 45(11): 905-907
Boehm, K.M.; Lawner, B.J.; McFee, R.B. 2003: Study raises important issues about the potential benefit of osteopathy in the cranial field to patients with Parkinson's disease Journal of the American Osteopathic Association 103(8): 354-5; author reply 355-6
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Watts, R.L.; Raiser, C.D.; Stover, N.P.; Cornfeldt, M.L.; Schweikert, A.W.; Allen, R.C.; Subramanian, T.; Doudet, D.; Honey, C.R.; Bakay, R.A.E. 2003: Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease Journal of Neural Transmission. Supplementum 2003(65): 215-227
Jankovic, J. 2001: Parkinson's disease therapy: treatment of early and late disease Chinese Medical Journal 114(3): 227-234
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Rasmussen, V.G.; Dupont, E.; Østergaard, K.; Egeblad, H. 2006: Valvular heart disease associated with the treatment of Parkinson disease Ugeskrift for Laeger 168(26-32): 2542-2544
Rabasseda, X. 1999: Perspectives in the treatment of Parkinson's disease: COMT inhibitors open up new treatment strategies Drugs of Today 35(9): 701-717
Vijayaraghavan, A.; Radhakrishnan, K. 1995: Treatment of Parkinson's disease Neurology India 43(2): 77-82